EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

NLRC4, inflammation and colorectal cancer (Review)

Guojun Tong, Yan Shen, Hui Li, Hai Qian, Zhenhua Tan

International Journal of Oncology · 2024

DOI: 10.3892/ijo.2024.5687 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2024. Verfasst von Guojun Tong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Huzhou Central Hospital, The Affiliated Central Hospital of Huzhou University, Huzhou, Zhejiang 313003, P.R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Calcium-Binding Proteins, CARD Signaling Adaptor Proteins, Inflammasomes. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation is recognized as a major risk factor for cancer and is involved in every phase of the disease. Inflammasomes are central to the inflammatory response and play a crucial role in cancer development. The present review summarizes the role of Nod‑like receptor C4 (NLRC4) in inflammation and colorectal cancer (CRC). Reviews of the literature were conducted using Web of Science, PubMed and CNKI, with search terms including 'NLRC4', 'colorectal cancer', 'auto‑inflammatory diseases' and 'prognosis'. Variants of NLRC4 can cause recessive immune dysregulation and autoinflammation or lead to ulcerative colitis as a heterozygous risk factor. Additionally, genetic mutations in inflammasome components may increase susceptibility to cancer. NLRC4 is considered a tumor suppressor in CRC. The role of NLRC4 in CRC signaling pathways is currently understood to involve five key aspects (caspase 1, NLRP3/IL‑8, IL‑1β/IL‑1, NAIP and p53). The mechanisms by which NLRC4 is involved in CRC are considered to be threefold (through pyroptosis, apoptosis, necroptosis and PANoptosis; regulating the immune response; and protecting intestinal epithelial cells to prevent CRC). However, the impact of NLRC4 mutations on CRC remains unclear. In conclusion, NLRC4 is a significant inflammasome that protects against CRC through various signaling pathways and mechanisms. The association between NLRC4 mutations and CRC warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsInflammasomesInflammationHumansSignal TransductionMutationGenetic Predisposition to Disease

Stichwörter der Autor:innen

Nod‑like receptor C4colorectal cancermechanism of actionprognosissignaling pathway

Substanzen

NLRC4 protein, humanCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsInflammasomes

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Huzhou Central Hospital, The Affiliated Central Hospital of Huzhou University, Huzhou, Zhejiang 313003, P.R. China.
  • Department of General Surgery, Huzhou Central Hospital, The Affiliated Central Hospital of Huzhou University, Huzhou, Zhejiang 313003, P.R. China.

Zitieren

APA

Tong, G., Shen, Y., Li, H., Qian, H., & Tan, Z. (2024). NLRC4, inflammation and colorectal cancer (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2024.5687

Vancouver

Tong G, Shen Y, Li H, Qian H, Tan Z. NLRC4, inflammation and colorectal cancer (Review). International Journal of Oncology. 2024. doi:10.3892/ijo.2024.5687

BibTeX
@article{Tong2024,
  author = {Tong, Guojun and Shen, Yan and Li, Hui and Qian, Hai and Tan, Zhenhua},
  title = {NLRC4, inflammation and colorectal cancer (Review)},
  journal = {International Journal of Oncology},
  year = {2024},
  doi = {10.3892/ijo.2024.5687}
}
Kostenlos starten →